Core Insights - DJS Law Group is investigating claims on behalf of investors of Stride, Inc. for potential violations of securities laws [1] - Stride reported Q1 financial results that exceeded estimates, but the company's forecasts for Q2 and the full year disappointed investors, leading to a significant drop in share price [2] Investigation Details - The investigation centers on whether Stride issued misleading statements or failed to disclose important information to investors [2] - Following the Q1 results announcement on October 28, 2025, Stride's shares fell by over 38% in after-hours trading due to disappointing forecasts [2]

Core Insights - DJS Law Group is investigating claims against Fiserv, Inc. for potential violations of securities laws [1][2] - Fiserv reported disappointing quarterly earnings and reduced its forward guidance, leading to a significant drop in share price [2] Investigation Details - The investigation centers on whether Fiserv made misleading statements or failed to disclose important information to investors [2] - Following the earnings report, Fiserv's shares fell by more than 43.6% during afternoon trading on October 29, 2025 [2] - CEO Mike Lyons indicated that the company's growth and margin targets need to be reset [2] Legal Context - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and asset managers [4] - The firm emphasizes the importance of respecting and focusing on the litigation claims of its clients [4]

Core Viewpoint - DJS Law Group is investigating claims against Vera Bradley, Inc. for potential violations of securities laws, particularly focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Investigation Details - The investigation centers on Vera Bradley's Q1 fiscal year 2026 financial results released on June 11, 2025, which disappointed investors. The CEO acknowledged ongoing negative trends in top line and profitability [2]. - Following the release of the disappointing financial results, Vera Bradley's shares experienced a significant decline of 19% on the same day [2]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

Core Viewpoint - DJS Law Group is investigating Larimar Therapeutics, Inc. for potential violations of securities laws related to misleading statements and undisclosed information regarding a clinical study [1][2]. Investigation Details - The investigation centers on Larimar's September 29, 2025 announcement of an open-label study involving daily subcutaneous injections of Nomlabofusp for Friedreich's Ataxia, which was presented as having positive results despite severe allergic reactions experienced by multiple participants [2]. - Following the release of this information, Larimar's shares experienced a significant decline of 33.66% [2]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

Core Viewpoint - The DJS Law Group is investigating claims on behalf of investors of America's Car-Mart, Inc. for potential violations of securities laws, particularly focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Investigation Details - The investigation centers on whether America's Car-Mart issued misleading statements or failed to disclose critical information to investors [2]. - On September 4, 2025, an article by Benzinga reported that America's Car-Mart experienced a first-quarter loss of 69 cents per share, a significant decline compared to a net loss of 15 cents per share in the same period the previous year [2]. - Following the release of these financial results, shares of America's Car-Mart dropped by over 18% on that day [2]. DJS Law Group's Focus - DJS Law Group aims to enhance investor returns through balanced counseling and aggressive advocacy, specializing in securities class actions, corporate governance litigation, and M&A appraisals [4]. - The firm represents some of the largest hedge funds and alternative asset managers globally, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - DJS Law Group is investigating claims against Informatica Inc. for potential violations of securities laws following disappointing financial results that led to a significant drop in share price [2]. Investigation Details - The investigation centers on whether Informatica made misleading statements or failed to disclose critical information to investors [2]. - Informatica reported a 3.8% year-over-year decrease in GAAP total revenues and a 2% year-over-year decrease in GAAP subscription revenues for Q4 2024 and the full year 2024 [2]. - Following the release of these results, Informatica's shares fell by more than 21% [2]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MOH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not requ ...

Core Viewpoint - Quantum BioPharma Ltd. strongly refutes allegations of securities law violations made by The Schall Law Firm and DJS Law Group, describing the claims as vague and unsubstantiated [1][2]. Company Overview - Quantum BioPharma is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders [5]. - The company is advancing its lead compound, Lucid-MS, which is designed to prevent and reverse myelin degradation associated with multiple sclerosis [5]. - Quantum BioPharma retains a 20.10% ownership stake in Unbuzzd Wellness Inc., which is linked to its product unbuzzd™, and has a royalty agreement that includes 7% of sales until reaching $250 million, after which the royalty will drop to 3% [5]. Legal Response - The company views the announcements from the law firms as opportunistic litigation tactics aimed at exploiting public markets without merit [3]. - Quantum BioPharma is reviewing the conduct of the law firms involved and plans to take appropriate action to protect its reputation [3]. Call for Information - The company invites individuals or entities who feel they have been treated unfairly by the law firms to come forward, assuring confidentiality [4].

Core Viewpoint - A class action lawsuit has been filed against PubMatic, Inc. for alleged violations of securities laws, specifically related to misleading statements about a decline in ad spending from a major buyer [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from February 27, 2025, to August 11, 2025, with a deadline for lead plaintiff appointments set for October 20, 2025 [2]. - The complaint alleges that PubMatic made false and misleading statements regarding its business performance, particularly concealing the loss of a top demand-side platform (DSP) buyer who shifted clients to a competitor [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff roles, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will receive updates through a portfolio monitoring software at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].

Core Viewpoint - A class action lawsuit has been filed against CTO Realty Growth, Inc. for alleged violations of securities laws, specifically related to misleading statements and dividend cuts [1][2]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 18, 2021, to June 24, 2025, with a deadline for lead plaintiff appointments set for October 7, 2025 [2]. - The complaint alleges that CTO Realty Growth made false and misleading statements, including overstating the profitability of the Ashford Lane property and its Adjusted Funds from Operations (AFFO) [2]. Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the law firm for potential lead plaintiff roles, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will receive updates through a portfolio monitoring software at no cost [3]. Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4].